New York Times |
Search for Eczema Relief Leads to Business Opportunities
New York Times The niche market for eczema sufferers has thrived because there is no widespread safe and effective treatment. In March, the Food and Drug Administration approved a drug, Dupixent, to treat eczema so severe that it cannot be controlled with other … |